Anti-CCDC94 antibody
Specifications
| Product Cat#: | AB-06-0815 |
| Product type: | Primary antibody |
| Antigen: | CCDC94 |
| Immunogen: | KLH conjugated synthetic peptide derived from human CCDC94 15-120/323 |
| Species immunized: | Rabbit |
| Isotype: | IgG |
| Applications: | Western Blot (1:550-1:2000); Immunohistochemistry-Paraffin (1:500-800) |
| Reactivity: | Mouse, Rat, Human |
| Clonality (clone number): | Polyclonal |
| Form: | Liquid |
| Buffer: | Tris-HCl buffer (pH7.4), 1% BSA, 0.03% Proclin300, 50% Glycerol. |
| Concentration: | 1 mg/ml |
| Purity: | Protein A affinity purified |
| Storage: | Aliquot and freeze at -20℃. Avoid multiple freeze/thaw cycles. |
| Alternative names: | Coiled coil domain containing protein 94 |
| FLJ10374 | |
| MGC156684 | |
| CCD94_HUMAN |
Show More
Target information
Part of the spliceosome which catalyzes two sequential transesterification reactions, first the excision of the non-coding intron from pre-mRNA and then the ligation of the coding exons to form the mature mRNA (PubMed:29301961). Plays a role in stabilizing the structure of the spliceosome catalytic core and docking of the branch helix into the active site, producing 5′-exon and lariat intron-3′-intermediates (By similarity). May protect cells from TP53-dependent apoptosis upon dsDNA break damage through association with PRP19-CD5L complex (PubMed:22952453).
Provider
Erpantech Laboratory